MacroGenics, Inc. (MGNX)
3.74
+0.19
(+5.35%)
USD |
NASDAQ |
Oct 09, 16:00
3.74
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Profit Margin (Quarterly) : -212.1% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -212.1% |
| March 31, 2026 | -177.0% |
| December 31, 2025 | -34.33% |
| September 30, 2025 | 23.09% |
| June 30, 2025 | -621.9% |
| March 31, 2025 | -311.1% |
| December 31, 2024 | -79.68% |
| September 30, 2024 | 50.86% |
| June 30, 2024 | -515.6% |
| March 31, 2024 | -573.3% |
| December 31, 2023 | -429.8% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | -155.2% |
| December 31, 2022 | 17.51% |
| September 30, 2022 | -59.46% |
| June 30, 2022 | -158.8% |
| March 31, 2022 | -598.5% |
| December 31, 2021 | -410.1% |
| September 30, 2021 | -337.7% |
| June 30, 2021 | -129.8% |
| March 31, 2021 | -303.7% |
| December 31, 2020 | -3.96% |
| September 30, 2020 | -197.5% |
| June 30, 2020 | -231.5% |
| Date | Value |
|---|---|
| March 31, 2020 | -326.9% |
| December 31, 2019 | -120.7% |
| September 30, 2019 | -238.1% |
| June 30, 2019 | -299.9% |
| March 31, 2019 | -465.9% |
| December 31, 2018 | -282.7% |
| September 30, 2018 | -163.6% |
| June 30, 2018 | -229.6% |
| March 31, 2018 | -1.06K% |
| December 31, 2017 | 69.39% |
| September 30, 2017 | -2.83K% |
| June 30, 2017 | -2.44K% |
| March 31, 2017 | -1.83K% |
| December 31, 2016 | -681.2% |
| September 30, 2016 | -1.04K% |
| June 30, 2016 | 50.16% |
| March 31, 2016 | -1.07K% |
| December 31, 2015 | -347.9% |
| September 30, 2015 | -105.2% |
| June 30, 2015 | -318.3% |
| March 31, 2015 | 63.31% |
| December 31, 2014 | -347.3% |
| September 30, 2014 | -21.37% |
| June 30, 2014 | -133.0% |
| March 31, 2014 | -21.12% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -134.2% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -222.4% |
| Return on Assets | -38.60% |
| Return on Invested Capital | -60.44% |
| Gross Profit Margin (Quarterly) | 97.84% |
| Operating Margin (Quarterly) | -42.19% |
| Return on Net Operating Assets | -154.9% |